Drug Trials Snapshot: IMAAVY
IMAAVY is a drug for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients 12 years of…
Mark J. Savant, M.D – 712306 – 06/26/2025
Clinical Investigator
MMC Healthcare Ltd. – 684644 – 09/24/2024
CGMP/Finished Pharmaceuticals/Adulterated
Marcus Research Laboratory, Inc. – 615153 – 10/02/2024
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Clean Solutions LLC – 686995 – 09/06/2024
CGMP/Finished Pharmaceuticals/Adulterated
Diamond Chemical Co., Inc. – 687078 – 09/06/2024
CGMP/Finished Pharmaceuticals/Adulterated
Little Moon Essentials, LLC – 677260 – 09/17/2024
CGMP/Finished Pharmaceuticals/Adulterated
Supercore Products Group, Inc. – 690510 – 09/26/2024
CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded
Makra Kozmetika D.O.O. – 684125 – 09/26/2024
CGMP/Finished Pharmaceuticals/Adulterated
Development of Cancer Drugs for Use in Novel Combination – Determining the Contribution of the Individual Drugs’ Effects
Development of Cancer Drugs for Use in Novel Combination – Determining the Contribution of the Individual Drugs’ Effects